Evidence map›Paper›PMID 25945149›Full record

ReviewOxidative medicine and cellular longevity2015

Inhibition of adenylyl cyclase type 5 increases longevity and healthful aging through oxidative stress protection.

Stephen F Vatner, Ronald E Pachon, Dorothy E Vatner

Open access · hybridAbstract readReview
In one paragraph

Review in Oxidative medicine and cellular longevity, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Scoping Review on ADCY5-Related Movement Disorders.Movement disorders clinical practice · 2023
    Article
  4. Review
  5. Expression and functions of adenylyl cyclases in the CNS.Fluids and barriers of the CNS · 2022
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Redox Regulation of Lipid Mobilization in Adipose Tissues.Antioxidants (Basel, Switzerland) · 2021
    Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Stephen F VatnerDepartments of Cell Biology & Molecular Medicine and Medicine, New Jersey Medical School, Rutgers University, Newark, NJ 07103, USA.
Ronald E PachonDepartments of Cell Biology & Molecular Medicine and Medicine, New Jersey Medical School, Rutgers University, Newark, NJ 07103, USA.
Dorothy E VatnerDepartments of Cell Biology & Molecular Medicine and Medicine, New Jersey Medical School, Rutgers University, Newark, NJ 07103, USA.
Rutgers, The State University of New Jersey · US

Funding

SFRP2, cell survival, and coronary vascular angiogenesisR01HL119464 · NHLBI · RBHS-NEW JERSEY MEDICAL SCHOOL · PI VATNER, DOROTHY EILEEN · 2013 to 2016
$1.8M
NHLBI NIH HHS R01 HL119464
6 · The paper itself

Abstract

Mice with disruption of adenylyl cyclase type 5 (AC5 knockout, KO) live a third longer than littermates. The mechanism, in part, involves the MEK/ERK pathway, which in turn is related to protection against oxidative stress. The AC5 KO model also protects against diabetes, obesity, and the cardiomyopathy induced by aging, diabetes, and cardiac stress and also demonstrates improved exercise capacity. All of these salutary features are also mediated, in part, by oxidative stress protection. For example, chronic beta adrenergic receptor stimulation induced cardiomyopathy was rescued by AC5 KO. Conversely, in AC5 transgenic (Tg) mice, where AC5 is overexpressed in the heart, the cardiomyopathy was exacerbated and was rescued by enhancing oxidative stress resistance. Thus, the AC5 KO model, which resists oxidative stress, is uniquely designed for clinical translation, since it not only increases longevity and exercise, but also protects against diabetes, obesity, and cardiomyopathy. Importantly, inhibition of AC5's action to prolong longevity and enhance healthful aging, as well as its mechanism through resistance to oxidative stress, is unique among all of the nine AC isoforms.

Indexed as

LongevityOxidative StressAdenylyl CyclasesAgingAnimalsCardiomyopathiesCell SurvivalDiabetes MellitusMAP Kinase Signaling SystemObesityAdenylyl Cyclasesadenylyl cyclase type V

Identifiers

PMID25945149
PMCPMC4405291
OpenAlexW2086198080

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.